Glyconics
PrivateLast Round
Seed
Nov 18, 2021
Total Funding Raised
$2.33M
Company Overview
Glyconics operates in Healthcare & Life Sciences and is based in Colchester. Its latest recorded funding round was a Seed round in November 2021.
Glyconics is a biotechnology company that develops spectroscopy-based diagnostic tools for the non-invasive detection and monitoring of respiratory diseases and diabetes.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Clinical Trials, Healthcare Analytics
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Glyconics Comparables
Compare Glyconics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| 1Drop Diagnostics | 81% | |
| Nostics | 79% | |
| DiaMonTech AG | 78% |
For institutional investors. Book with your work email.
Glyconics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 18, 2021 | ||||
| Grant | Oct 15, 2020 | ||||
| Grant | Feb 19, 2018 |
For institutional investors. Book with your work email.
Glyconics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deepbridge Capital | Seed |
| Wealth Club | Seed |
| Defence and Security Accelerator | Grant |
| Boundary Capital Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 28, 2025
Monthly visitors grew 34% MoM.
- Nov 18, 2021
$2M round led by Wealth Club.
For institutional investors. Book with your work email.
Glyconics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Glyconics's valuation, stock price, and market status.
Is Glyconics a public or private company?
Glyconics is a private company.
What is the current stock price of Glyconics?
Glyconics is a private company, so its shares have no public market price. Caplight tracks Glyconics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Glyconics worth (valuation)?
Valuation information for Glyconics is not publicly available.
Can I buy Glyconics stock?
Glyconics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Glyconics's last funding round?
Glyconics's most recent funding round was Seed on November 18, 2021.
Who are the main investors in Glyconics?
Key investors in Glyconics include Wealth Club.
Will Glyconics IPO soon?
No public IPO plans have been announced for Glyconics.
How can I track Glyconics secondary market activity?
Caplight tracks bids, offers, and trades in Glyconics's shares on secondary markets.